Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Clinical Trial ID NCT00329719

PubWeight™ 12.98^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00329719

Top papers